Back

Lac-Phe mediates the anti-obesity effect of metformin

Xiao, S.; Li, V. L.; Lyu, X.; Chen, X.; Wei, W.; Abbasi, F.; Knowles, J.; Deng, S.; Tiwari, G.; Shi, X.; Deng, S.; Farrell, L.; Chen, Z.-Z.; Taylor, K.; Guo, X.; Goodarzi, M.; Wood, A.; Chen, Y.-D. I.; Lange, L.; Rich, S. S.; Rotter, J.; Clish, C. B.; Tahir, U.; Gerszten, R. E.; Benson, M.; Long, J. Z.

2023-11-04 physiology Community evaluation
10.1101/2023.11.02.565321 bioRxiv
Show abstract

Metformin is a widely prescribed anti-diabetic medicine that also reduces body weight. The mechanisms that mediate metformins effects on energy balance remain incompletely defined. Here we show that metformin is a powerful pharmacological inducer of the anorexigenic metabolite Lac-Phe in mice as well as in two independent human cohorts. In cell culture, metformin drives Lac-Phe biosynthesis via inhibition of complex I, increased glycolytic flux, and intracellular lactate mass action. Other biguanides and structurally distinct inhibitors of oxidative phosphorylation also increase Lac-Phe levels in vitro. Genetic ablation of CNDP2, the principal biosynthetic enzyme for Lac-Phe, in mice renders animals resistant to metformins anorexigenic and anti-obesity effects. Mediation analyses also support a role for Lac-Phe in metformins effect on body mass index in humans. These data establish the CNDP2/Lac-Phe pathway as a critical mediator of the effects of metformin on energy balance.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.